cobicistat / darunavir / emtricitabine / tenofovir alafenamide Oral Product
RxNorm concept 2049668, clinical dose form group (scdg).
- RxCUI
- 2049668
- Term type
- Clinical dose form group (SCDG)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2049668 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- emtricitabine (IN, has ingredient)
- darunavir (IN, has ingredient)
- cobicistat (IN, has ingredient)
- tenofovir alafenamide (IN, has ingredient)
- Symtuza Oral Product (SBDG, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2049668 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2049668 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2049668. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.